作者单位：
European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium
[1]
Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL of Bologna, Italy,Department of Medical Oncology, Bellaria-Maggiore Hospital, Via Altura 3, 40139 Bologna Italy
[2]
Department of Medical Oncology, Bellaria-Maggiore Hospital, Azienda USL of Bologna, Italy
[3]
University of Lausanne Hospitals, Lausanne, Switzerland
[4]
Service de Neurologie Mazarin, Hopital de la Pitie-Salpetriere, Paris, France
[5]
Laboratory of Brain Tumor Biology and Genetics, University Hospital Lausanne (CHUV) and University of Lausanne, Lausanne, Switzerland
[6]
Department of Pathology, Lausanne University Hospital, Lausanne, Switzerland
[7]
Bristol-Myers Squibb Inc., Wallingford, Connecticut
[8]
Neuro-Oncology Unit, Department of Neurology, Daniel den Hoed Cancer Center/Erasmus Medical Center, Rotterdam, The Netherlands
[9]
Departments of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
[10]
发布时间
2013-11-20
换一批
